You can buy or sell AKTX and other stocks, options, ETFs, and crypto commission-free!
Akari Therapeutics Plc ADR, also called Akari Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. Read More The company was founded on October 7, 2004 and is headquartered in London, the United Kingdom.
London, London & South East
52 Week High
52 Week Low
Expected Nov 26, Pre-Market